X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
91
PharmaCompass offers a list of Orlistat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Orlistat manufacturer or Orlistat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Orlistat manufacturer or Orlistat supplier.
PharmaCompass also assists you with knowing the Orlistat API Price utilized in the formulation of products. Orlistat API Price is not always fixed or binding as the Orlistat Price is obtained through a variety of data sources. The Orlistat Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Orlistat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Orlistat, including repackagers and relabelers. The FDA regulates Orlistat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Orlistat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Orlistat manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Orlistat supplier is an individual or a company that provides Orlistat active pharmaceutical ingredient (API) or Orlistat finished formulations upon request. The Orlistat suppliers may include Orlistat API manufacturers, exporters, distributors and traders.
click here to find a list of Orlistat suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Orlistat DMF (Drug Master File) is a document detailing the whole manufacturing process of Orlistat active pharmaceutical ingredient (API) in detail. Different forms of Orlistat DMFs exist exist since differing nations have different regulations, such as Orlistat USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Orlistat DMF submitted to regulatory agencies in the US is known as a USDMF. Orlistat USDMF includes data on Orlistat's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Orlistat USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Orlistat suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Orlistat Drug Master File in Korea (Orlistat KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Orlistat. The MFDS reviews the Orlistat KDMF as part of the drug registration process and uses the information provided in the Orlistat KDMF to evaluate the safety and efficacy of the drug.
After submitting a Orlistat KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Orlistat API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Orlistat suppliers with KDMF on PharmaCompass.
A Orlistat written confirmation (Orlistat WC) is an official document issued by a regulatory agency to a Orlistat manufacturer, verifying that the manufacturing facility of a Orlistat active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Orlistat APIs or Orlistat finished pharmaceutical products to another nation, regulatory agencies frequently require a Orlistat WC (written confirmation) as part of the regulatory process.
click here to find a list of Orlistat suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Orlistat as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Orlistat API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Orlistat as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Orlistat and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Orlistat NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Orlistat suppliers with NDC on PharmaCompass.
Orlistat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Orlistat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Orlistat GMP manufacturer or Orlistat GMP API supplier for your needs.
A Orlistat CoA (Certificate of Analysis) is a formal document that attests to Orlistat's compliance with Orlistat specifications and serves as a tool for batch-level quality control.
Orlistat CoA mostly includes findings from lab analyses of a specific batch. For each Orlistat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Orlistat may be tested according to a variety of international standards, such as European Pharmacopoeia (Orlistat EP), Orlistat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Orlistat USP).
Market Place
